| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |